The Potential Role of Chemoprevention in the Management of Non-Muscle Invasive Bladder Urothelial Carcinoma

QR Code

The Potential Role of Chemoprevention in the Management of Non-Muscle Invasive Bladder Urothelial Carcinoma

None

Saved in:

Bibliographic Details
Main Authors:	Nseyo, Unyime O., Corbyons, Katherine A., Tunuguntla, Hari Siva Gurunadha Rao
Format:	Electronic Book Chapter
Language:	English
Published:	IntechOpen 2012
Subjects:	Health Sciences
Online Access:	https://www.intechopen.com/chapters/27325
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Chemoprevention and Novel Treatments of Non-Muscle Invasive Bladder Cancer
by: Luchey, Adam, et al.
Published: (2012)

Sarcopenia in Urothelial Bladder Carcinoma: A Narrative Review
by: Constantin Radu Vrabie, et al.
Published: (2025-07-01)

Robot-assisted cystectomy in treatment of patients with bladder urothelial carcinoma
by: V. A. Oganyan, et al.
Published: (2023-07-01)

Rectal metastasis from bladder urothelial carcinoma: a case report
by: Yuki Ii, et al.
Published: (2021-04-01)

Local cytokine levels as prognostic factors for early relapse of non-muscle-invasive bladder carcinoma
by: E. Yu. Zlatnik, et al.
Published: (2023-06-01)

High-grade non-muscle invasive urothelial carcinoma in dogs and humans share specific expression of integrin α5β1
by: Roberta Lucianò, et al.
Published: (2025-05-01)

TREATMENT OF NON-MUSCLE-INVASIVE HIGH-RISK BLADDER CANCER
by: S. A. Ivanov, et al.
Published: (2017-07-01)

Fluorescence cystoscopy in patients with non-muscle invasive bladder cancer
by: I. G. Rusakov, et al.
Published: (2015-09-01)

Non-muscle invasive bladder cancer in a pregnant patient
by: Návan van Jaarsveld, et al.
Published: (2025-09-01)

Correction: High-grade non-muscle invasive urothelial carcinoma in dogs and humans share specific expression of integrin α5β1
by: Roberta Lucianò, et al.
Published: (2025-06-01)

Long non-coding RNA urothelial carcinoma–associated 1 as a tumor biomarker for the diagnosis of urinary bladder cancer
by: Zichun Wang, et al.
Published: (2017-06-01)

Current capabilities of endoscopic diagnosis of non-muscle invasive bladder cancer
by: I. N. Zaborskii, et al.
Published: (2020-06-01)

SOCIAL AND CLINICAL CHARACTERISTICS OF PATIENTS WITH NON-MUSCLE-INVASIVE BLADDER CANCE
by: A. D. Kaprin, et al.
Published: (2018-05-01)

Comparison of thulium and holmium lasers with conventional transurethral bladder resection for non-muscle invasive bladder cancer
by: S. V. Popov, et al.
Published: (2024-07-01)

Results of chemoradiotherapyfor muscle-invasive bladder cancer
by: Yu. V. Gumenetskaya, et al.
Published: (2016-02-01)

Urine microbiota in non-muscle-invasive bladder cancer and approaches to its detection
by: M. I. Kogan, et al.
Published: (2024-07-01)

Urothelial Carcinoma in Renal Transplant Recipients
by: Lai, Ming-Kuen, et al.
Published: (2011)

Molecular genetic subtypes of non-muscle-invasive bladder cancer: their impact on disease prognosis
by: Sh. M. Sargsian, et al.
Published: (2025-07-01)

Transformation from prostate adenocarcinoma to high-grade invasive urothelial carcinoma: A case report
by: Dihao Lv, et al.
Published: (2025-08-01)

Trimodal organ‑preserving treatment of muscle‑invasive bladder cancer
by: A. V. Troianov, et al.
Published: (2023-03-01)

Current Advances in the Perioperative Treatment of Muscle-Invasive Bladder Cancer
by: Ursula Vogl, et al.
Published: (2025-06-01)

Laboratory predictors to intravesical BCG therapy response in patients with non-muscle invasive bladder cancer
by: S. Yu. Konyashkina, et al.
Published: (2023-01-01)

Muscle non-invasive bladder cancer: clinical and morphological features, treatment outcomes, survival analysis
by: K. B. Lelyavin, et al.
Published: (2013-09-01)

Impact of regular cystoscopy on prognosis in non–muscle-invasive bladder cancer: A nationwide study
by: Jeong-Soo Kim, et al.
Published: (2025-07-01)

Potential of Urinary Mutation and Methylation Biomarkers in Selecting Candidates for Repeat Transurethral Resection of Bladder Tumor in Non–muscle-invasive Bladder Cancer: A Prospective Multicenter Study
by: Xiao Yang, et al.
Published: (2025-07-01)

Identification of a risk model for prognostic and therapeutic prediction in bladder urothelial carcinoma based on infiltrating CD8+ T cells
by: Ligang Ma, et al.
Published: (2025-12-01)

Altered expression of small leucine-rich proteoglycans (Decorin, Biglycan and Lumican): Plausible diagnostic marker in urothelial carcinoma of bladder
by: Sandeep Appunni, et al.
Published: (2017-04-01)

Chemopreventive effect of omega-3 polyunsaturated fatty acids and atorvastatin in rats with bladder cancer
by: Nahla E El-Ashmawy, et al.
Published: (2017-02-01)

The number of cancer stem cells in the tumor tissue and perifocal tissue of non-muscle invasive bladder cancer
by: L. I. Belyakova, et al.
Published: (2022-03-01)

NEOADJUVANT CHEMOTHERAPY WITH RADICAL CYSTECTOMY IN THE TREATMENT OF MUSCLE-INVASIVE BLADDER CANCER
by: N. S. Nurgaliev, et al.
Published: (2016-10-01)

Histological and immunohistochemical approaches to molecular subtyping in muscle-invasive bladder cancer
by: Giulio Attanasio, et al.
Published: (2025-07-01)

Immune Checkpoint Inhibitors in Urothelial Carcinoma (Literature Review)
by: K. V. Menshikov, et al.
Published: (2022-10-01)

Urothelial Carcinoma: Role of Biomarkers in Diagnosis, Prognosis and Treatment
by: Ioannis Zachos
Published: (2025-07-01)

Development and validation of nomograms for predicting prognosis in patients with resectable bladder urothelial carcinoma undergoing radical cystectomy: a multicenter retrospective study
by: Junjie Ji, et al.
Published: (2025-07-01)

The role of multiparametric magnetic resonance imaging in the differentiation of low- and high-grade non-muscle invasive bladder cancer
by: Merve Nur Taşdemir, et al.
Published: (2025-07-01)

Metastatic anal cloacogenic cell carcinoma misdiagnosed as urothelial carcinoma with long survival
by: Burak Bilgin, et al.
Published: (2017-07-01)

Pseudocholinesterase levels and atherogenic indices as indicators of invasive and non-invasive bladder cancer
by: Hasan N. Smeasm, et al.
Published: (2025-07-01)

Optimizing compliance and efficacy in intravesical BCG therapy for non-muscle invasive bladder cancer: tailored strategies and clinical outcomes
by: G. Shubhankar, et al.
Published: (2025-01-01)

Long-term effect of treatment for non-muscle invasive bladder cancer on Quality of life: a cross-sectional study
by: Rikke Vilsbøll Milling, et al.
Published: (2025-07-01)

Intravesical Therapy of Superficial Urothelial Bladder Cancer with BCG and Epirubicin 50 Mg - Comparative Analysis
by: Boyan Atanasov, et al.
Published: (2022-06-01)